AllNewsPhotosVideos

Glenmark Pharmaceuticals Ltd

Glenmark pharmaceuticals ltd, Latest News

Glenmark gets USFDA approval for Clindamycin Phosphate Foam 1% - Hindi News | Glenmark gets USFDA approval for Clindamycin Phosphate Foam 1% | Latest health News at Lokmatnews.in

Health :Glenmark gets USFDA approval for Clindamycin Phosphate Foam 1%

Chennai, Sep 21 Pharma major Glenmark Pharmaceuticals Ltd on Tuesday said it has received final approval by the ... ...

Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1% - Hindi News | Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1% | Latest business News at Lokmatnews.in

Business :Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%

Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharmaceuticals Inc. ...

Glenmark concludes post marketing surveillance (PMS) study on Favipiravir (FabiFlu®) - Hindi News | Glenmark concludes post marketing surveillance (PMS) study on Favipiravir (FabiFlu®) | Latest business News at Lokmatnews.in

Business :Glenmark concludes post marketing surveillance (PMS) study on Favipiravir (FabiFlu®)

Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India. ...

Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19 - Hindi News | Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19 | Latest national News at Lokmatnews.in

National :Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19

The Glenmark Pharmaceuticals' post-marketing surveillance (PMS) study has shown no safety concerns with the use of Favipiravir (FabiFlu®[?]) in India for COVID-19 infection. ...

Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19 - Hindi News | Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19 | Latest national News at Lokmatnews.in

National :Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19

The Glenmark Pharmaceuticals' post-marketing surveillance (PMS) study has shown no safety concerns with the use of Favipiravir (FabiFlu®[?]) in India for COVID-19 infection. ...

Fitch affirms Glenmark Pharmaceuticals at BB on IPO of API business - Hindi News | Fitch affirms Glenmark Pharmaceuticals at BB on IPO of API business | Latest business News at Lokmatnews.in

Business :Fitch affirms Glenmark Pharmaceuticals at BB on IPO of API business

Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB after its active pharmaceutical ingredient (API) business completed an initial public offering (IPO). ...

Glenmark to make, market SaNOtize's nasal spray against Covid-19 - Hindi News | Glenmark to make, market SaNOtize's nasal spray against Covid-19 | Latest health News at Lokmatnews.in

Health :Glenmark to make, market SaNOtize's nasal spray against Covid-19

Chennai, Aug 2 Pharma major Glenmark Pharmaceuticals Ltd on Monday said it has signed a long term partnership ... ...

Glenmark, Canada's SaNOtize to commercialise nasal spray for Covid-19 treatment - Hindi News | Glenmark, Canada's SaNOtize to commercialise nasal spray for Covid-19 treatment | Latest business News at Lokmatnews.in

Business :Glenmark, Canada's SaNOtize to commercialise nasal spray for Covid-19 treatment

Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research and Development Corp on Monday announced an exclusive long term strategic partnership to manufacture, market and distribute nitric oxide nasal spray (NONS) for Covid-19 treatment in ...